Introduction
Cells of the macrophage lineage play a crucial role in initial HIV-1 infection and contribute to the pathogenesis of the disease throughout the course of infection. Both monocytes and macrophages are considered as major cell targets for HIV-1 infection. [1] [2] [3] However, peripheral blood monocytes are infrequently infected with HIV-1 in vivo and in vitro and only a very small proportion of them (0.001%-1%) harbor HIV-1 at any given time throughout the course of infection. [2] [3] [4] In contrast, tissue macrophages are readily susceptible to HIV-1 infection in vivo. 3, [5] [6] [7] [8] [9] These in vivo findings are supported by the in vitro observations, showing that peripheral blood isolated-monocytes acquire the ability to support productive HIV-1 infection only after their differentiation to macrophages 7, 10, 11 and that HIV-1 replication in monocytes is generally enhanced by factors that facilitate differentiation. [12] [13] [14] These studies suggest that host innate immunity plays a key role in governing HIV-1 infection of monocyte/macrophages.
Since HIV-1 R5 strains utilize CCR5 as a primary co-receptor for entry into macrophages, the demonstration 10,15 of differential expression of the CCR5 receptor on monocytes and macrophages has been suggested as an explanation for the differential susceptibility of monocytes and macrophages to HIV-1 infection. However, this observation does not account fully for differences in HIV-1 infectivity in monocytes and macrophages. 10, 15, 16 Recent studies 16, 17 showed that several members of APOBEC family members (APOBEC3G/3F), the newly identified HIV-1 restriction factors, [18] [19] [20] [21] are differentially expressed in immature monocytes and differentiated macrophages.
While monocytes express high levels of functional APOBEC3G proteins, APOBEC3G in macrophages is sequestered in an inactive ribonucleoprotein complex, which increases macrophages permissibility to HIV-1 infection.
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Methods and Materials

Healthy Donor and Cells Culture
Peripheral blood was purchased from University of Pennsylvania, Center for AIDS Research (CFAR). The protocol used to isolate blood from donors, purify the blood components and distribute this material to the University of Pennsylvania was approved by the IRB of the Center for AIDS Research. The donors gave informed consent in accordance with the Declaration of Helsinki for their blood to be used in this manner. The samples was screened for the common blood-born pathogens and certified to be pathogen-free. Monocytes were purified from peripheral blood of three healthy adult donors according to our previously described technique. 24 Freshly isolated monocytes were cultured in 96-well culture plates at a density of 5 X 10 4 cells/well in Dulbecco's Modied Eagls's medium (DMEM) containing 10% fetal calf serum. Macrophages refer to sevenday-cultured monocytes in vitro. 
Transfection of miRNA mimics and miRNA inhibitors and HIV-1 Infection
The miRNA mimics and miRNA inhibitors for miRNA-28, miRNA-150, miRNA-223 or miRNA-382 were chemically synthesized by Dharmacon (Lafayette, Co). The design of miRNA mimic negative control 2 (miRNA Ctl) and miRNA inhibitor negative control 2 (Anti-miRNA Ctl) was previously described. 23 
Results and Discussion
HIV-1 replication and the anti-HIV-1 miRNA expression in monocytes/macrophages
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We first compared the susceptibility of D0 monocytes and D7-cultured macrophages to HIV-1 infection. Freshly isolated monocytes were either infected with HIV-1 Bal strain immediately after isolation (Day 0) or cultured for 7 days in vitro when the majority of monocytes differentiated to macrophages (the insert in Fig.1 A) . Macrophages were infected with HIV-1 Bal at the same titer as for donor-matched monocytes. As anticipated, HIV-1 Bal-infected D0 monocytes exhibited minimal evidence of HIV-1 replication, while donor-matched macrophages were highly permissive to HIV-1 infection as evidenced by a steady increase of RT activity during the period of cultures (Fig. 1A) . In parallel, we also determined the expression of the miRNAs 28, 150, 223 and 382, the newly identified HIV-1 restriction factors, in monocytes/macrophages during the course of differentiation. Because very few monocytes harbor HIV-1 in vivo and monocytes are poorly susceptible to HIV-1 infection in vitro, we hypothesized that monocytes may have high levels of the anti-HIV-1 miRNAs, contributing to their refractory property to HIV-1 infection. This speculation is supported by the observation that D0 monocytes expressed the highest levels of intracellular miRNAs 28, 150, 223 and 382 than the cells cultured at later time points of the in vitro differentiation (Fig. 1B) . The lowest levels of these miRNAs were observed in the cells cultured for 7 days (Fig. 1B) when the majority of monocytes differentiate into macrophages (the insert in Fig.   1A ). These observations demonstrated that although both monocytes and macrophages expressed the anti-HIV-1 miRNAs, the levels of these miRNAs in monocytes and macrophages significantly differ, which was correlated with the extent of cell's permissibility to HIV-1 infection.
Modulation of anti-HIV-1 miRNA expression alters permissibility of cells to HIV-1 infection
In order to demonstrate the crucial role of the anti-HIV-1 miRNAs in protecting of monocytes/macrophages from HIV-1 infection, we examined whether the modulation of the anti-HIV-1 miRNA levels in monocytes/macrophages could alter the cell's susceptibility to HIV-1 For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
